HLA Class I-restricted MYD88 L265P-derived Peptides As Specific Targets for Lymphoma Immunotherapy.
OncoImmunology（2016）
关键词
Cancer vaccine,HLA,ligandome,immunotherapy,MyD88 L265P,neoantigen,non-Hodgkin lymphoma,peptide vaccination
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要